Ishita Drugs & Industries Ltd (524400) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524400 | NSE: | Pharmaceuticals & Drugs | Small Cap

Ishita Drugs & Inds. Share Price

72.44 0.00 0.00%
as on 04-Dec'25 16:59

Ishita Drugs & Industries Ltd (524400) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524400 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Ishita Drugs & Inds.

Based on:

M-Cap below 100cr DeciZen not available

Ishita Drugs & Industries stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
22.31
Market Cap:
21.7 Cr.
52-wk low:
62.4
52-wk high:
99.6

Is Ishita Drugs & Industries Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Ishita Drugs & Inds.: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Ishita Drugs & Industries Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 4%4.8%7.3%8.2%10.8%14.4%13%8.9%10.7%10%-
Value Creation
Index
-0.7-0.7-0.5-0.4-0.20.0-0.1-0.4-0.2-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 6.55.86.89.114.81414.112.115.21517
Sales YoY Gr.--10.7%15.9%34.3%63.2%-5.9%1%-14.3%25.9%-1.3%-
Adj EPS 0.50.60.711.62.12.61.82.32.83.3
YoY Gr.-22%6.6%47.7%62.5%37.2%21.5%-30.8%26.1%22.5%-
BVPS (₹) 18.819.420.321.523.326.128.830.733.236.137.6
Adj Net
Profit
0.20.20.20.30.50.60.80.50.70.81
Cash Flow from Ops. 0.30.50.70.81.1-0.73.1-2.92.1-3.6-
Debt/CF from Ops. 4.300.20.30.3-0.10-0.30-1.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.7%0.2%2.1%-1.3%
Adj EPS 21%12.3%2.3%22.5%
BVPS7.5%9.2%7.9%8.7%
Share Price 13.5% 23.5% 11.7% -19.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2.73.23.34.678.79.56.17.188.8
Op. Profit
Mgn %
4.15.56.75.75.26.67.76.366.76.5
Net Profit
Mgn %
2.33.12.93.13.14.65.54.54.55.65.7
Debt to
Equity
0.20000000.100.40
Working Cap
Days
141145105725062558067104171
Cash Conv.
Cycle
645649273113254579121

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Ishita Drugs & Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 3.3 -
TTM Sales (₹ Cr.) 17.2 -
BVPS (₹.) 37.6 -
Reserves (₹ Cr.) 8 -
P/BV 1.93 -
PE 22.31 -
From the Market
52 Week Low / High (₹) 62.35 / 99.64
All Time Low / High (₹) 0.10 / 104.75
Market Cap (₹ Cr.) 21.7
Equity (₹ Cr.) 3
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Ishita Drugs & Inds.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Ishita Drugs & Inds. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Ishita Drugs & Inds.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales6.545.846.779.0914.8313.9514.0912.0715.1915
Operating Expenses 6.295.556.328.5714.0713.031311.3114.2814
Manufacturing Costs0.270.420.410.680.770.720.630.530.550.79
Material Costs5.023.954.716.3711.4110.2310.148.5111.2210.54
Employee Cost 0.410.450.560.670.760.760.760.770.830.83
Other Costs 0.590.730.640.861.121.321.471.501.691.83
Operating Profit 0.250.290.450.520.760.921.090.760.911
Operating Profit Margin (%) 3.8%4.9%6.7%5.7%5.1%6.6%7.7%6.3%6.0%6.7%
Other Income 0.150.150.120.160.160.310.110.200.280.34
Interest 0.060.040.110.060.030.030.020.050.090.07
Depreciation 0.150.140.140.160.180.150.130.130.110.11
Exceptional Items 0000000000
Profit Before Tax 0.190.260.320.460.711.051.040.780.991.16
Tax 0.060.070.080.110.170.220.240.200.240.29
Profit After Tax 0.140.180.250.350.550.830.800.580.750.87
PAT Margin (%) 2.1%3.1%3.7%3.9%3.7%5.9%5.7%4.8%4.9%5.8%
Adjusted EPS (₹)0.50.60.81.21.82.82.71.92.52.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 5.635.816.066.416.967.798.609.179.9210.79
Share Capital 2.992.992.992.992.992.992.992.992.992.99
Reserves 2.642.823.073.423.974.805.616.186.937.80
Minority Interest0000000000
Debt1.110.010.090.130.21000.9603.90
Long Term Debt000.080.120.0400000.09
Short Term Debt1.110.01000.17000.9603.81
Trade Payables1.261.180.561.381.890.982.040.860.460.95
Others Liabilities 0.210.180.440.420.480.490.620.420.430.65
Total Liabilities 8.207.197.158.349.559.2611.2511.4110.8116.30

Fixed Assets

Gross Block4.114.164.464.734.754.754.604.734.764.84
Accumulated Depreciation33.143.283.433.613.763.713.843.953.96
Net Fixed Assets 1.111.021.191.301.1410.880.890.800.88
CWIP 0000000000
Investments 2.152.703.154.045.293.114.063.393.343.87
Inventories0.770.560.720.740.580.650.971.601.064.46
Trade Receivables1.881.700.821.181.311.520.541.800.701.90
Cash Equivalents flag 2.191.111.201.0112.544.683.434.814.83
Others Assets 0.090.100.080.070.220.440.110.300.090.35
Total Assets 8.207.197.158.349.559.2611.2511.4110.8116.30

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.260.520.720.791.05-0.673.08-2.902.12-3.64
PBT 0.190.260.320.460.711.051.040.780.991.16
Adjustment 0.060.030.130.050.05-0.140.05-0.02-0.08-0.15
Changes in Working Capital 0.080.320.350.390.46-1.362.24-3.451.45-4.34
Tax Paid -0.07-0.09-0.08-0.12-0.18-0.23-0.25-0.21-0.24-0.30
Cash Flow From Investing Activity -0.28-0.55-0.69-1.06-1.152.45-0.930.590.13-0.67
Capex -0.01-0.04-0.310000-0.13-0.03-0.18
Net Investments -0.33-0.51-0.38-1.06-1.272.18-0.970.670.06-0.53
Others 0.060000.120.270.040.060.100.05
Cash Flow From Financing Activity 1.07-1.050.050.090.09-0.2401.05-0.874.33
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -0.06-0.04-0.11-0.06-0.03-0.03-0.02-0.05-0.09-0.07
Dividend Paid 0000000000
Others 1.13-10.160.150.13-0.210.031.10-0.784.40
Net Cash Flow 1.05-1.080.08-0.19-0.011.542.14-1.251.380.02

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)2.473.194.175.648.1811.259.826.57.848.38
ROCE (%)4.024.797.268.1710.7914.39138.910.749.97
Asset Turnover Ratio0.940.840.961.171.661.481.371.071.371.11
PAT to CFO Conversion(x)1.862.892.882.261.91-0.813.85-52.83-4.18
Working Capital Days
Receivable Days811026740313727353032
Inventory Days53383429161621393267
Payable Days861136856525154622124

Ishita Drugs & Industries Ltd Stock News

Ishita Drugs & Industries Ltd FAQs

The current trading price of Ishita Drugs & Inds. on 04-Dec-2025 16:59 is ₹72.44.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2025 the market cap of Ishita Drugs & Inds. stood at ₹21.66.
The latest P/E ratio of Ishita Drugs & Inds. as of 03-Dec-2025 is 22.31.
The latest P/B ratio of Ishita Drugs & Inds. as of 03-Dec-2025 is 1.93.
The 52-week high of Ishita Drugs & Inds. is ₹99.64 and the 52-week low is ₹62.35.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ishita Drugs & Inds. is ₹17.16 ( Cr.) .

About Ishita Drugs & Industries Ltd

Ishita drugs & industries limited (IDIL), an Ishita Group company  was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

IDIL is engaged in the manufacture of various active pharma ingredients (bulk actives and their salts), bulk drug intermediates, excipients and fine chemicals. It has a state-of-art manufacturing facility, in terms of chemical synthesis, quality control and environmental safety.

Ishita Group is a respected member of the Indian business community for more than 3 decades. The group's interests encompass manufacture of a large number of bulk actives and their salts, drug intermediates, fine chemicals, food additives, specialty/ performance chemicals, pharmaceutical formulations, healthcare products, dyes and dye intermediates, distribution of financial products and other businesses. The ishita group derives its key strengths from its strong ethical practices and moral values in business commitments.

The company’s manufacturing facility is located on main State Highway 17, barely 25 km from Ahmedabad city. The plant incorporates facilities that are the state-of-art in chemical synthesis, quality control and energy efficiency. The provision of several different utility systems and equipments covering a large number of unit operations make the plant truly multi-purpose. This imparts the flexibility to alter the product mix in tune with the changing market needs or the needs of the customers for customized products.

The plant is equipped with various kinds of equipment to carry out varied kinds of reactions - ss vessels, glass lined ss reactors (glrs), ss centrifuges, rubber lined centrifuges, condensers, fluid bed dryers, ribbon blender, commuting mill, leaf filters, vibrator separators, multi mill etc. The plant also have various utilities suitable for different processes - oil heating, steam heating, ammonia chilling, brine chilling, compressed air, vacuum systems etc.

Product range of the company includes:

The current product list of Ishita includes APIs and intermediates

APIs

Antibiotics

  • Chloramphenicol bp/usp
  • Chloramphenicol palmitate bp/usp

Fluoro quinolones

  • Norfloxacin ip/usp/bp
  • Enrofloxacin base vet

Sulpha drugs

  • Sulfacetamide plain bp/usp
  • Sulphacetamide sodium (drc)
  • Sulfanilamide

Vitamins

  • Nicotinamide usp (inj.) / cosmetics grade
  • Nicotinic acid bp/usp

Anthelmintics

  • Piperazine hydrate
  • Piperazine citrate / adipate / phosphate

Iodides & citrates (salts)

  • Pot.iodide bp
  • Sod.iodide bp
  • Methyl iodide bp
  • Pot.citrate bp/usp
  • Sod.citrate bp/usp
  • Sod.acid citrate bp
  • Sodium chloride bp (pyrogen free)
  • Potassium chloride bp (pyrogen free)

Excipients

  • Maize starch bp
  • Sod.starch glycolate usp
  • Pumojel (sod.starch glycolate)

Other chemicals

  • Methyl nicotinate
  • Pyrazinamide
  • Salicylanilide
  • Para bromo toluene 99.5%
  • Pyridine hydrobromide
  • Potassium phthalimide
  • Nicotinic acid hydrazide

Intermediaries

  • 4-sulfonamido phenyl hydrazine hcl (celecoxib intermediate)
  • 4-chloro phenyl hydrazine hydrochloride
  • Q-acid and n2 ester (norfloxacin intermediates)
  • Tri methyl sulphonoxium iodide
  • 5 cyano phthalide
  • 7-amino - 3 phenyl coumarin
  • 2-hydroxy methyl 3,5 dimethyl 4-methoxy pyridine (omeprazole int.)
  • Hexa methyl disilazane
  • 5-chloromethopabate
  • Diacetyl sulfanilamide
  • L-alanine benzylester p-toluene sulfonate salt
  • 4 (chloroacetyl) n-methyl sulfonamide
  • Indole - 2 - carboxylic acid
  • Ethyl benzoyl acrylate
  • 4, 4' - dimethyl benzil
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×